Company profile
Nammi Therapeutics, Inc.
Nammi aims to improve cancer care by co-delivering combinations of immunotherapy to tumor using proprietary technologies
- Industry
- Biotechnology Research
- Employees
- 8
- Headquarters
- Los Angeles, CA
- LinkedIn followers
- 861
- Office locations
- 1
Nammi Therapeutics, Inc. company summary
Nammi Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Los Angeles, CA. On LinkedIn the company has around 8 employees and 861 followers.
What technology does Nammi Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. is an immuno-oncology company based in Los Angeles that is developing platforms and products that selectively activate anti-tumor immunity within the tumor microenvironment while minimizing systemic activation. By reducing systemic activation of the immune system, Nammi expects to improve safety and enhance the ability to combine multiple immune modulators. Nammi’s lead product candidate, QXL138AM, is a Masked Immunocytokine (MIC) targeting a masked interferon to the tumor antigen, CD138. In addition to the MIC platform, Nammi has also developed a nanoparticle platform to deliver Immune Modulating Prodrugs (IMPs) using their Nammisome technology. Multiple Nammisome clinical candidates have also been selected for development.
Where is Nammi Therapeutics, Inc. located?
Nammi Therapeutics, Inc. lists 1 location.
Compare companies similar to Nammi Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Nammi Therapeutics, Inc. nammirx.com | Biotechnology Research | 8 | - | Los Angeles, CA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Nammi Therapeutics, Inc.
What does Nammi Therapeutics, Inc. do?
Nammi Therapeutics, Inc. is an immuno-oncology company based in Los Angeles that is developing platforms and products that selectively activate anti-tumor immunity within the tumor microenvironment while minimizing systemic activation. By reducing systemic activation of the immune system, Nammi expects to improve safety and enhance the ability to combine multiple immune modulators. Nammi’s lead product candidate, QXL138AM, is a Masked Immunocytokine (MIC) targeting a masked interferon to the tumor antigen, CD138. In addition to the MIC platform, Nammi has also developed a nanoparticle platform to deliver Immune Modulating Prodrugs (IMPs) using their Nammisome technology. Multiple Nammisome clinical candidates have also been selected for development.
How many employees does Nammi Therapeutics, Inc. have?
Nammi Therapeutics, Inc. has around 8 employees on LinkedIn.
Where is Nammi Therapeutics, Inc. headquartered?
Nammi Therapeutics, Inc. is headquartered in Los Angeles, CA.
Build a lead list from companies like Nammi Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.